What is Keurig Dr Pepper Inc.'s earnings per share (EPS)?

Keurig Dr Pepper Inc. (KDP) reported diluted earnings per share of $1.53 for fiscal year 2025. This represents a 45.7% change compared to the previous fiscal year. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

Keurig Dr Pepper Inc. (KDP) Financials

KDP

Trailing 12 months to June 30, 2026

Revenue $20.1B +27.5% YoY

Net Income $1.4B -7.1% YoY

EPS (Diluted) $0.99 -11.6% YoY

Free Cash Flow $2.0B +23.0% YoY

Market Cap $41.6B as of Oct 8, 2026

Price / Sales 2.1x on $20.1B revenue, trailing 12 months to June 30, 2026

Price / Earnings 29.1x on $1.4B net income, trailing 12 months to June 30, 2026

Price / Book 1.7x on $25.0B equity, Q2 FY2026

A multiple compares the market's price with a filed figure; it says what the market pays, not how the business is doing. The market capitalization is the vendor's as of Oct 8, 2026; every other figure is from the SEC filings on this page. Not financial advice.

Source SEC Filings (10-K/10-Q) Latest period Q2 FY2026, ended Jun 30, 2026 Reported Aug 10, 2026 Currency USD FYE December

Newest figures come from the 10-Q for Q2 FY2026, filed Aug 10, 2026. Each column of the statement tables below links to the filing it was taken from, and every filing is listed on the KDP SEC filings page.

Keurig Dr Pepper Inc. (KDP) reported $20.1B in revenue over the twelve months to Jun 30, 2026, up 27.5% from the prior twelve months. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 15 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Rhea AI KDP FY2025 2026-10-04

Keurig Dr Pepper grows sales while profit margins recover, but cash conversion and tight short-term liquidity remain central constraints.

2025 earnings improved faster than cash generation: net income reached $2.1B while operating cash flow was $2.0B and free cash flow was $1.5B. That gap, alongside inventory rising to $1.7B, suggests more earnings were tied up in working capital and reinvestment rather than immediately becoming spendable cash.

Margin recovery came mainly below gross profit, not from a broad improvement in product-level economics: gross margin eased to 54.2% from 55.6% in FY2024, while operating margin rebounded to 21.5% from 16.9%. This points to improved operating cost absorption or discipline, though the available figures do not isolate the exact cause.

The balance sheet remains structurally asset-heavy and financially committed: total liabilities reached $29.9B against $25.5B of equity, while the current ratio was only 0.6x. Free cash flow of $1.5B also sat only modestly above $1.3B of dividends, leaving capital allocation dependent on maintaining ongoing cash generation.

Financial Health Signals

Financial Health Score 50/100

Scored against operating companies for FY2025. Each of the six dimensions is a percentile rank within that peer group; the overall is their average, with missing dimensions counted as zero out of six. A high score means strong standing among peers, not absolute cross-industry strength. How this score is calculated →

Health score ≠ stock price. This rates the quality of Keurig Dr Pepper Inc.'s business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.

Profitability

Keurig Dr Pepper Inc. has an operating margin of 21.5%, meaning the company retains $22 of operating profit per $100 of revenue. This strong profitability earns a score of 87/100, reflecting efficient cost management and pricing power. This is up from 16.9% the prior year.

Growth

Keurig Dr Pepper Inc.'s revenue grew 8.2% year-over-year to $16.6B, a solid pace of expansion. This earns a growth score of 53/100.

Leverage

Keurig Dr Pepper Inc. has elevated debt relative to equity (D/E of 0.51), meaning the company relies heavily on borrowed funds. This high leverage results in a low score of 23/100, reflecting increased financial risk.

Liquidity

Keurig Dr Pepper Inc.'s current ratio of 0.64 is below the typical benchmark, resulting in a score of 7/100. This tight liquidity could limit financial flexibility if cash inflows slow.

Cash Flow

Keurig Dr Pepper Inc. has a free cash flow margin of 9.1%, earning a moderate score of 63/100. The company generates positive cash flow after capital investments, but with room for improvement.

Returns

Keurig Dr Pepper Inc. earns a strong 8.2% return on equity (ROE), meaning it generates $8 of profit for every $100 of shareholders' equity. This efficient capital use earns a returns score of 66/100. This is up from 5.9% the prior year.

Altman Z-Score Distress

1.42

Keurig Dr Pepper Inc. scores 1.42, below the 1.81 distress threshold. The score is driven primarily by a large market capitalization ($41.6B) relative to total liabilities ($29.9B). This indicates elevated financial distress risk and warrants close attention to liquidity and debt levels.

Distress-screening estimate for non-financial companies. Not computed for banks or insurers, where the Altman model does not apply.

Piotroski F-Score Neutral

6/9

Keurig Dr Pepper Inc. passes 6 of 9 financial strength tests. 3 of 4 profitability signals pass, 2 of 3 leverage/liquidity signals pass, 1 of 2 efficiency signals pass.

Earnings Quality Mixed

0.96x

For every $1 of reported earnings, Keurig Dr Pepper Inc. generates $0.96 in operating cash flow ($2.0B OCF vs $2.1B net income). This mixed ratio suggests some earnings may rely on non-cash accounting items.

Interest Coverage Adequate

4.74x

Keurig Dr Pepper Inc. earns $4.74 in operating income for every $1 of interest expense ($3.6B vs $754.0M). This adequate coverage means the company can meet its interest obligations, but has limited cushion if earnings fall.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue

$7.3B

YoY+75.6%

QoQ+83.8%

5Y CAGR+18.4%

10Y CAGR+15.7%

Keurig Dr Pepper Inc. generated $7.3B in revenue in Q2 2026. This represents an increase of 75.6% from the same quarter a year earlier. Against the prior quarter it is up 83.8%.

EBITDA

$993.0M

YoY-7.3%

QoQ+6.0%

5Y CAGR+2.2%

10Y CAGR+8.6%

Keurig Dr Pepper Inc.'s EBITDA was $993.0M in Q2 2026, measuring earnings before interest, taxes, depreciation, and amortization. This represents a decrease of 7.3% from the same quarter a year earlier. Against the prior quarter it is up 6.0%.

Net Income

$142.0M

YoY-74.0%

QoQ-47.4%

5Y CAGR-20.5%

10Y CAGR-5.9%

Keurig Dr Pepper Inc. reported $142.0M in net income in Q2 2026. This represents a decrease of 74.0% from the same quarter a year earlier. Against the prior quarter it is down 47.4%.

EPS (Diluted)

$0.04

5Y CAGR-33.6%

10Y CAGR-29.9%

Keurig Dr Pepper Inc. earned $0.04 per diluted share (EPS) in Q2 2026.

Cash & Balance Sheet

Free Cash Flow

$714.0M

YoY+119.7%

QoQ+332.7%

5Y CAGR+8.1%

10Y CAGR+14.2%

Keurig Dr Pepper Inc. generated $714.0M in free cash flow in Q2 2026, representing cash available after capex. This represents an increase of 119.7% from the same quarter a year earlier. Against the prior quarter it is up 332.7%.

Cash & Debt

$1.5B

YoY+198.0%

QoQ+68.9%

5Y CAGR+55.5%

10Y CAGR+20.0%

Keurig Dr Pepper Inc. held $1.5B in cash against $21.6B in long-term debt as of Q2 2026.

Dividends Per Share

$0.23

Keurig Dr Pepper Inc. paid $0.23 per share in dividends in Q2 2026.

Shares Outstanding

1.36B

5Y CAGR-0.8%

10Y CAGR+22.1%

Keurig Dr Pepper Inc. had 1.36B shares outstanding in Q2 2026.

Margins & Returns

Gross Margin

41.9%

YoY-12.2pp

QoQ-10.8pp

5Y change-14.4pp

10Y change-18.5pp

Keurig Dr Pepper Inc.'s gross margin was 41.9% in Q2 2026, indicating the percentage of revenue retained after direct costs. This is down 12.2 percentage points from the same quarter a year earlier. Against the prior quarter it is down 10.8 percentage points.

Operating Margin

8.6%

YoY-13.0pp

QoQ-10.4pp

5Y change-14.8pp

10Y change-15.7pp

Keurig Dr Pepper Inc.'s operating margin was 8.6% in Q2 2026, reflecting core business profitability. This is down 13.0 percentage points from the same quarter a year earlier. Against the prior quarter it is down 10.4 percentage points.

Net Margin

1.9%

YoY-11.2pp

QoQ-4.9pp

5Y change-12.3pp

10Y change-13.4pp

Keurig Dr Pepper Inc.'s net profit margin was 1.9% in Q2 2026, showing the share of revenue converted to profit. This is down 11.2 percentage points from the same quarter a year earlier. Against the prior quarter it is down 4.9 percentage points.

Return on Equity

0.6%

YoY-1.6pp

QoQ-0.5pp

5Y change-1.3pp

10Y change-11.6pp

Keurig Dr Pepper Inc.'s ROE was 0.6% in Q2 2026, measuring profit generated per dollar of shareholder equity. This is down 1.6 percentage points from the same quarter a year earlier. Against the prior quarter it is down 0.5 percentage points.

Capital Allocation

Capital Expenditures

$181.0M

YoY+70.8%

QoQ+56.0%

5Y CAGR+10.7%

10Y CAGR+16.0%

Keurig Dr Pepper Inc. invested $181.0M in capex in Q2 2026, funding long-term assets and infrastructure. This represents an increase of 70.8% from the same quarter a year earlier. Against the prior quarter it is up 56.0%.

R&D Spending

Not reported for Q2 2026.

Share Buybacks

Not reported for Q2 2026.

KDP Income Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

KDP quarterly income statement

Metric	TTM	FY2510-K	FY2410-K	FY2310-K	FY2210-K	FY2110-K	FY2010-K	FY1910-K	FY1810-K	FY1710-K	FY1610-K	FY1510-K	FY1410-K	FY1310-K	FY1210-K	FY1110-K
Revenue	$20.1B	$16.6B+8.2%	$15.4B+3.6%	$14.8B+5.4%	$14.1B+10.8%	$12.7B+9.2%	$11.6B+4.5%	$11.1B+49.4%	$7.4B+74.3%	$4.3B-33.7%	$6.4B+2.5%	$6.3B+2.6%	$6.1B+2.1%	$6.0B0.0%	$6.0B+1.6%	$5.9B
Cost of Revenue	$10.2B	$7.6B+11.5%	$6.8B+1.3%	$6.7B0.0%	$6.7B+18.0%	$5.7B+11.2%	$5.1B+7.4%	$4.8B+34.2%	$3.6B+60.0%	$2.2B-13.8%	$2.6B+0.9%	$2.6B+2.7%	$2.5B-0.3%	$2.5B0.0%	$2.5B+0.6%	$2.5B
Gross Profit	$9.9B	$9.0B+5.5%	$8.5B+5.6%	$8.1B+10.3%	$7.3B+5.0%	$7.0B+7.6%	$6.5B+2.3%	$6.3B+63.4%	$3.9B-2.8%	$4.0B+3.6%	$3.9B+3.6%	$3.7B+2.6%	$3.6B+3.8%	$3.5B+0.1%	$3.5B+2.3%	$3.4B
R&D Expenses	N/A	$70.0M0.0%	$70.0M+6.1%	$66.0M+1.5%	$65.0M-1.5%	$66.0M-4.3%	$69.0M-14.8%	$81.0M+26.6%	$64.0M+220.0%	$20.0M0.0%	$20.0M+5.3%	$19.0M+5.6%	$18.0M-14.3%	$21.0M0.0%	$21.0M+40.0%	$15.0M
SG&A Expenses	$6.5B	$5.4B+6.7%	$5.0B+2.1%	$4.9B+5.7%	$4.6B+11.8%	$4.2B+4.4%	$4.0B+0.4%	$4.0B+50.4%	$2.6B+3.1%	$2.6B+9.7%	$2.3B+0.7%	$2.3B-0.9%	$2.3B+2.7%	$2.3B+0.2%	$2.3B+0.5%	$2.3B
Operating Income	$3.3B	$3.6B+38.0%	$2.6B-18.8%	$3.2B+22.5%	$2.6B-10.0%	$2.9B+16.7%	$2.5B+4.3%	$2.4B+92.2%	$1.2B-10.9%	$1.4B-3.1%	$1.4B+10.4%	$1.3B+10.0%	$1.2B+12.8%	$1.0B-4.2%	$1.1B+6.6%	$1.0B
EBITDA	N/A	$4.3B+32.1%	$3.2B-15.0%	$3.8B+18.5%	$3.2B-8.1%	$3.5B+15.9%	$3.0B+3.8%	$2.9B+82.9%	$1.6B+6.8%	$1.5B-2.7%	$1.5B+9.2%	$1.4B+8.3%	$1.3B+11.5%	$1.2B-4.5%	$1.2B+5.7%	$1.1B
Interest Expense	$1.0B	$754.0M+2.6%	$735.0M+48.2%	$496.0M-28.4%	$693.0M+38.6%	$500.0M-17.2%	$604.0M-7.6%	$654.0M+63.1%	$401.0M+144.5%	$164.0M+11.6%	$147.0M+25.6%	$117.0M+7.3%	$109.0M-11.4%	$123.0M-1.6%	$125.0M+9.6%	$114.0M
Income Tax	$476.0M	$608.0M+28.5%	$473.0M-17.9%	$576.0M+102.8%	$284.0M-56.5%	$653.0M+52.6%	$428.0M-2.7%	$440.0M+117.8%	$202.0M+112.6%	$95.0M-78.1%	$434.0M+3.3%	$420.0M+13.2%	$371.0M+558.0%	-$81.0M-123.2%	$349.0M+9.1%	$320.0M
Net Income	$1.4B	$2.1B+44.3%	$1.4B-33.9%	$2.2B+51.9%	$1.4B-33.1%	$2.1B+62.0%	$1.3B+5.7%	$1.3B+114.0%	$586.0M-45.5%	$1.1B+27.0%	$847.0M+10.9%	$764.0M+8.7%	$703.0M+12.7%	$624.0M-0.8%	$629.0M+3.8%	$606.0M
EPS (Basic)	N/A	$1.53+44.3%	$1.06-32.1%	$1.56+54.5%	$1.01-33.6%	$1.52+61.7%	$0.94+5.6%	$0.89+64.8%	$0.54-90.9%	$5.91+29.3%	$4.57+14.3%	$4.00+11.4%	$3.59+16.6%	$3.08+3.0%	$2.99+7.9%	$2.77
EPS (Diluted)	$0.99	$1.53+45.7%	$1.05-32.3%	$1.55+53.5%	$1.01-32.7%	$1.50+61.3%	$0.93+5.7%	$0.88+66.0%	$0.53	$5.89+29.7%	$4.54+14.4%	$3.97+11.5%	$3.56+16.7%	$3.05+3.0%	$2.96+8.0%	$2.74
Diluted Shares (Avg)	N/A	1.36B-0.4%	1.37B-2.8%	1.41B-1.4%	1.43B0.0%	1.43B+0.4%	1.42B+0.2%	1.42B+29.3%	1.10B	183M-2.0%	187M-3.0%	192M-2.5%	197M-3.5%	205M-3.7%	212M-4.0%	221M

Metric	Q2'2610-Q	Q1'2610-Q	Q4'2510-Q	Q3'2510-Q	Q2'2510-Q	Q1'2510-Q	Q4'2410-K	Q3'2410-Q
Revenue	$7.3B+75.6%	$4.0B+9.4%	$4.5B+10.5%	$4.3B+10.7%	$4.2B+6.1%	$3.6B+4.8%	$4.1B+5.2%	$3.9B+2.3%
Cost of Revenue	$4.2B+122.4%	$1.9B+13.8%	$2.1B+16.0%	$2.0B+12.3%	$1.9B+9.0%	$1.6B+8.0%	$1.8B+6.5%	$1.8B+3.4%
Gross Profit	$3.1B+36.0%	$2.1B+5.7%	$2.4B+6.2%	$2.3B+9.3%	$2.3B+3.8%	$2.0B+2.3%	$2.3B+4.3%	$2.1B+1.4%
SG&A Expenses	$2.4B+76.8%	$1.3B+12.6%	$1.5B+12.5%	$1.3B+8.0%	$1.4B+4.7%	$1.2B+1.4%	$1.3B+3.1%	$1.2B+2.3%
Operating Income	$628.0M-30.1%	$756.0M-5.6%	$881.0M+1298.4%	$995.0M+10.3%	$898.0M+4.3%	$801.0M+4.7%	$63.0M-93.3%	$902.0M+0.7%
EBITDA	$993.0M-7.3%	$937.0M-3.3%	$1.1B+407.6%	$1.2B+9.7%	$1.1B+3.9%	$969.0M+4.3%	$210.0M-80.9%	$1.1B+2.1%
Interest Expense	$336.0M+86.7%	$281.0M+89.9%	$238.0M-3.6%	$188.0M+77.4%	$180.0M-11.8%	$148.0M-16.9%	$247.0M-73.4%	$106.0M+144.7%
Income Tax	$95.0M-44.4%	$87.0M-39.2%	$104.0M+1140.0%	$190.0M+2.2%	$171.0M+8.9%	$143.0M+2.1%	-$10.0M-104.9%	$186.0M+27.4%
Net Income	$142.0M-74.0%	$270.0M-47.8%	$353.0M+345.1%	$662.0M+7.5%	$547.0M+6.2%	$517.0M+13.9%	-$144.0M-120.8%	$616.0M+18.9%
EPS (Basic)	$0.04-90.0%	$0.20-47.4%	$0.26+360.0%	$0.49+8.9%	$0.40+5.3%	$0.38+15.2%	-$0.10-120.0%	$0.45+21.6%
EPS (Diluted)	$0.04	$0.20-47.4%	$0.26+336.4%	$0.49+8.9%	$0.40+5.3%	$0.38+15.2%	-$0.11-122.0%	$0.45+21.6%
Diluted Shares (Avg)	1.36B	1.36B+0.1%	N/A	1.36B+0.1%	1.36B+0.1%	1.36B-1.8%	N/A	1.36B-3.2%

Not reported in any period shown, so not listed: R&D Expenses.

KDP Balance Sheet

KDP quarterly balance sheet

Metric	FY2510-K	FY2410-K	FY2310-K	FY2210-K	FY2110-K	FY2010-K	FY1910-K	FY1810-K	FY1710-K	FY1610-K	FY1510-K	FY1410-K	FY1310-K	FY1210-K	FY1110-K
Total Assets	$55.5B+3.8%	$53.4B+2.5%	$52.1B+0.6%	$51.8B+2.4%	$50.6B+1.6%	$49.8B+0.5%	$49.5B+1.2%	$48.9B+203.7%	$16.1B+64.5%	$9.8B+10.4%	$8.9B+7.3%	$8.3B+0.8%	$8.2B-8.1%	$8.9B-3.8%	$9.3B
Current Assets	$5.3B+31.7%	$4.0B+18.4%	$3.4B-11.3%	$3.8B+24.4%	$3.1B+28.0%	$2.4B+5.1%	$2.3B+5.3%	$2.2B+55.3%	$1.4B-49.2%	$2.7B+50.6%	$1.8B+50.0%	$1.2B+8.2%	$1.1B-16.2%	$1.3B-24.0%	$1.8B
Cash & Equivalents	$1.0B+101.2%	$510.0M+91.0%	$267.0M-50.1%	$535.0M-5.6%	$567.0M+136.3%	$240.0M+220.0%	$75.0M-9.6%	$83.0M+25.8%	$66.0M-96.3%	$1.8B+96.2%	$911.0M+284.4%	$237.0M+54.9%	$153.0M-58.2%	$366.0M-47.8%	$701.0M
Short-Term Investments	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0
Inventory	$1.7B+33.4%	$1.3B+13.7%	$1.1B-13.1%	$1.3B+47.0%	$894.0M+17.3%	$762.0M+16.5%	$654.0M+4.5%	$626.0M+32.1%	$474.0M+134.7%	$202.0M-3.3%	$209.0M+2.5%	$204.0M+2.0%	$200.0M+1.5%	$197.0M-7.1%	$212.0M
Accounts Receivable	$1.7B+11.3%	$1.5B+9.8%	$1.4B-7.8%	$1.5B+29.3%	$1.1B+9.5%	$1.0B-6.0%	$1.1B-3.0%	$1.1B+157.3%	$447.0M-24.9%	$595.0M+4.4%	$570.0M+2.5%	$556.0M-1.4%	$564.0M+2.2%	$552.0M-5.6%	$585.0M
Long-Term Investments	$0	$0	$0	$0	$0	$0	$0	$0-100.0%	$46.0M+31.4%	$35.0M+40.0%	$25.0M0.0%	$25.0M+19.0%	$21.0M	$0	$0
Goodwill	$20.2B+1.0%	$20.1B-0.7%	$20.2B+0.6%	$20.1B-0.5%	$20.2B0.0%	$20.2B+0.1%	$20.2B+0.8%	$20.0B+103.6%	$9.8B+228.4%	$3.0B+0.2%	$3.0B-0.1%	$3.0B+0.1%	$3.0B+0.2%	$3.0B+0.1%	$3.0B
Total Liabilities	$29.9B+2.6%	$29.2B+10.3%	$26.5B-1.0%	$26.7B+4.2%	$25.6B-1.2%	$25.9B-1.2%	$26.3B-0.5%	$26.4B+191.2%	$9.1B+18.3%	$7.7B+14.5%	$6.7B+12.0%	$6.0B+0.8%	$5.9B-10.9%	$6.6B-5.3%	$7.0B
Current Liabilities	$8.3B+2.5%	$8.1B-9.3%	$8.9B+10.4%	$8.1B+24.5%	$6.5B-15.7%	$7.7B+18.8%	$6.5B+13.5%	$5.7B+197.9%	$1.9B+82.1%	$1.1B-33.6%	$1.6B+52.5%	$1.0B+0.8%	$1.0B-16.4%	$1.2B-35.7%	$1.9B
Non-Current Liabilities	$21.7B+2.6%	$21.1B+20.3%	$17.5B-5.9%	$18.6B-2.6%	$19.1B+4.9%	$18.3B-7.7%	$19.8B-4.3%	$20.7B+189.4%	$7.1B+8.2%	$6.6B+29.5%	$5.1B+3.4%	$4.9B+0.8%	$4.9B-9.6%	$5.4B+6.1%	$5.1B
Long-Term Debt	$13.0B+1.0%	$12.9B+29.8%	$9.9B-10.2%	$11.1B-4.4%	$11.6B+3.9%	$11.1B-13.1%	$12.8B-9.7%	$14.2B+288.0%	$3.7B-18.1%	$4.5B+55.4%	$2.9B+11.4%	$2.6B+2.9%	$2.5B-1.8%	$2.6B+13.6%	$2.2B
Total Equity	$25.5B+5.3%	$24.2B-5.6%	$25.7B+2.2%	$25.1B+0.6%	$25.0B+4.8%	$23.8B+2.5%	$23.3B+3.2%	$22.5B+230.0%	$6.8B+220.0%	$2.1B-2.2%	$2.2B-4.8%	$2.3B+0.7%	$2.3B-0.1%	$2.3B+0.8%	$2.3B
Retained Earnings	$5.6B+17.3%	$4.8B+5.1%	$4.6B+28.8%	$3.5B+10.6%	$3.2B+55.2%	$2.1B+30.3%	$1.6B+34.3%	$1.2B+249.6%	$337.0M-85.1%	$2.3B+4.7%	$2.2B+22.2%	$1.8B+27.1%	$1.4B+29.0%	$1.1B+45.9%	$740.0M

Metric	Q2'2610-Q	Q1'2610-Q	Q4'2510-Q	Q3'2510-Q	Q2'2510-Q	Q1'2510-Q	Q4'2410-K	Q3'2410-Q
Total Assets	$87.6B+61.2%	$73.1B+36.2%	$55.5B+3.8%	$54.6B+3.6%	$54.4B+3.9%	$53.7B+2.7%	$53.4B+2.5%	$52.7B+1.8%
Current Assets	$9.5B+105.4%	$23.1B+432.3%	$5.3B+31.7%	$4.7B+14.6%	$4.6B+20.6%	$4.3B+21.8%	$4.0B+18.4%	$4.1B+20.4%
Cash & Equivalents	$1.5B+198.0%	$898.0M+37.5%	$1.0B+101.2%	$516.0M-6.5%	$509.0M+16.2%	$653.0M+106.0%	$510.0M+91.0%	$552.0M+112.3%
Short-Term Investments	$0	$0	$0	$0	$0	$0	$0	$0
Inventory	$3.9B+121.5%	$1.8B+18.8%	$1.7B+33.4%	$1.8B+36.2%	$1.7B+39.1%	$1.5B+27.8%	$1.3B+13.7%	$1.4B+0.2%
Accounts Receivable	$2.4B+61.7%	$1.5B+15.8%	$1.7B+11.3%	$1.5B+3.4%	$1.5B+7.8%	$1.3B+1.4%	$1.5B+9.8%	$1.4B+13.2%
Long-Term Investments	$0	$0	$0	$0	$0	$0	$0	$0
Goodwill	$29.8B+47.1%	$20.2B+0.7%	$20.2B+1.0%	$20.2B+0.6%	$20.2B+0.7%	$20.1B-0.5%	$20.1B-0.7%	$20.1B-0.2%
Total Liabilities	$54.0B+83.7%	$39.5B+35.2%	$29.9B+2.6%	$29.3B+5.5%	$29.4B+6.4%	$29.3B+5.9%	$29.2B+10.3%	$27.7B+5.1%
Current Liabilities	$19.7B+173.4%	$10.0B+9.3%	$8.3B+2.5%	$7.5B-2.2%	$7.2B-3.8%	$9.2B+30.9%	$8.1B-9.3%	$7.7B-12.7%
Non-Current Liabilities	$34.2B+54.5%	$29.5B+47.0%	$21.7B+2.6%	$21.8B+8.5%	$22.2B+10.2%	$20.1B-2.7%	$21.1B+20.3%	$20.1B+14.0%
Long-Term Debt	$21.6B+55.1%	$20.9B+75.2%	$13.0B+1.0%	$13.5B+9.0%	$13.9B+12.2%	$11.9B-7.8%	$12.9B+29.8%	$12.4B+24.9%
Total Equity	$25.0B+0.2%	$25.3B+3.3%	$25.5B+5.3%	$25.3B+1.4%	$25.0B+1.1%	$24.4B-0.8%	$24.2B-5.6%	$25.0B-1.6%
Retained Earnings	$5.3B+1.8%	$5.6B+11.7%	$5.6B+17.3%	$5.6B+6.3%	$5.2B+5.8%	$5.0B+5.8%	$4.8B+5.1%	$5.2B+26.0%

KDP Cash Flow Statement

KDP quarterly cash flow statement

Metric	TTM	FY2510-K	FY2410-K	FY2310-K	FY2210-K	FY2110-K	FY2010-K	FY1910-K	FY1810-K	FY1710-K	FY1610-K	FY1510-K	FY1410-K	FY1310-K	FY1210-K	FY1110-K
Operating Cash Flow	$2.5B	$2.0B-10.3%	$2.2B+67.0%	$1.3B-53.2%	$2.8B-1.3%	$2.9B+17.0%	$2.5B-0.7%	$2.5B+53.4%	$1.6B+55.4%	$1.0B+8.0%	$961.0M-5.2%	$1.0B-0.8%	$1.0B+18.0%	$866.0M+79.7%	$482.0M-38.4%	$783.0M
Depreciation & Amortization	N/A	$706.0M+8.6%	$650.0M+4.8%	$620.0M+1.1%	$613.0M+1.0%	$607.0M+12.0%	$542.0M+1.9%	$532.0M+50.3%	$354.0M+247.1%	$102.0M+3.0%	$99.0M-5.7%	$105.0M-8.7%	$115.0M0.0%	$115.0M-7.3%	$124.0M-1.6%	$126.0M
Stock-Based Compensation	N/A	$97.0M-1.0%	$98.0M-15.5%	$116.0M+123.1%	$52.0M-40.9%	$88.0M+3.5%	$85.0M+32.8%	$64.0M+82.9%	$35.0M-2.8%	$36.0M-20.0%	$45.0M+2.3%	$44.0M-8.3%	$48.0M+29.7%	$37.0M+5.7%	$35.0M+2.9%	$34.0M
Capital Expenditures	$557.0M	$486.0M-13.7%	$563.0M+32.5%	$425.0M+20.4%	$353.0M-16.5%	$423.0M-8.2%	$461.0M+39.7%	$330.0M+83.3%	$180.0M-10.9%	$202.0M+12.2%	$180.0M+0.6%	$179.0M+5.3%	$170.0M-5.0%	$179.0M-17.5%	$217.0M-8.8%	$238.0M
Free Cash Flow	$2.0B	$1.5B-9.1%	$1.7B+83.2%	$904.0M-63.6%	$2.5B+1.3%	$2.5B+22.9%	$2.0B-6.9%	$2.1B+49.6%	$1.4B+71.4%	$836.0M+7.0%	$781.0M-6.5%	$835.0M-2.0%	$852.0M+24.0%	$687.0M+159.2%	$265.0M-51.4%	$545.0M
Investing Cash Flow	-$17.2B	-$573.0M+64.5%	-$1.6B-105.9%	-$784.0M+30.9%	-$1.1B-640.5%	$210.0M+166.5%	-$316.0M-110.7%	-$150.0M+99.2%	-$19.1B-985.1%	-$1.8B-832.8%	-$189.0M+2.6%	-$194.0M-4.9%	-$185.0M+5.1%	-$195.0M+10.1%	-$217.0M+9.6%	-$240.0M
Financing Cash Flow	$16.0B	-$999.0M-348.0%	-$223.0M+73.2%	-$832.0M+51.9%	-$1.7B+37.4%	-$2.8B-38.8%	-$2.0B+15.8%	-$2.4B-113.4%	$17.6B+2037.9%	-$907.0M-939.8%	$108.0M+178.8%	-$137.0M+81.7%	-$747.0M+15.1%	-$880.0M-45.9%	-$603.0M-296.7%	-$152.0M
Dividends Paid	$1.2B	$1.3B+4.7%	$1.2B+4.6%	$1.1B+5.7%	$1.1B+13.1%	$955.0M+12.9%	$846.0M+0.2%	$844.0M+263.8%	$232.0M+321.8%	$55.0M-85.8%	$386.0M+8.7%	$355.0M+12.0%	$317.0M+5.0%	$302.0M+6.3%	$284.0M+13.1%	$251.0M
Share Buybacks	N/A	$9.0M-99.2%	$1.1B+57.2%	$706.0M+86.3%	$379.0M	$0	$0	N/A	$0-100.0%	$399.0M-23.1%	$519.0M-0.4%	$521.0M+30.3%	$400.0M0.0%	$400.0M0.0%	$400.0M-23.4%	$522.0M

Metric	Q2'2610-Q	Q1'2610-Q	Q4'2510-Q	Q3'2510-Q	Q2'2510-Q	Q1'2510-Q	Q4'2410-K	Q3'2410-Q
Operating Cash Flow	$895.0M+107.7%	$281.0M+34.4%	$712.0M-16.1%	$639.0M+1.8%	$431.0M-34.4%	$209.0M+145.9%	$849.0M+185.9%	$628.0M+8.3%
Depreciation & Amortization	$365.0M+111.0%	$181.0M+7.7%	$185.0M+25.9%	$180.0M+6.5%	$173.0M+1.8%	$168.0M+2.4%	$147.0M-7.0%	$169.0M+10.5%
Stock-Based Compensation	$177.0M+669.6%	$30.0M+36.4%	N/A	$25.0M+4.2%	$23.0M-4.2%	$22.0M-21.4%	N/A	$24.0M-17.2%
Capital Expenditures	$181.0M+70.8%	$116.0M-3.3%	$148.0M-10.3%	$112.0M-10.4%	$106.0M-7.8%	$120.0M-24.1%	$165.0M+7.1%	$125.0M+2.5%
Free Cash Flow	$714.0M+119.7%	$165.0M+85.4%	$564.0M-17.5%	$527.0M+4.8%	$325.0M-40.0%	$89.0M+221.9%	$684.0M+378.3%	$503.0M+9.8%
Investing Cash Flow	-$16.8B-7502.3%	-$98.0M-71.9%	-$183.0M+83.0%	-$112.0M+46.4%	-$221.0M-62.5%	-$57.0M+70.5%	-$1.1B-568.3%	-$209.0M+50.2%
Financing Cash Flow	-$1.1B-171.9%	$17.6B+252085.7%	-$65.0M-123.1%	-$525.0M-86.2%	-$402.0M-5.8%	-$7.0M-104.4%	$281.0M+308.1%	-$282.0M-62.1%
Dividends Paid	$312.0M-0.3%	$312.0M0.0%	$313.0M+0.6%	$312.0M+6.8%	$313.0M+7.2%	$312.0M+4.3%	$311.0M+3.7%	$292.0M+4.7%
Share Buybacks	N/A	N/A	$0-100.0%	$0	$9.0M	$0-100.0%	$5.0M-98.0%	$0

KDP Financial Ratios

Margins and returns are percentages; the remaining ratios are unitless multiples. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

KDP quarterly financial ratios

Metric	FY2510-K	FY2410-K	FY2310-K	FY2210-K	FY2110-K	FY2010-K	FY1910-K	FY1810-K	FY1710-K	FY1610-K	FY1510-K	FY1410-K	FY1310-K	FY1210-K	FY1110-K
Gross Margin	54.2%-1.4pp	55.6%+1.0pp	54.5%+2.4pp	52.1%-2.9pp	55.0%-0.8pp	55.8%-1.2pp	57.0%+4.9pp	52.2%-41.4pp	93.6%+33.7pp	59.9%+0.6pp	59.3%0.0pp	59.3%+1.0pp	58.3%0.0pp	58.3%+0.4pp	57.9%
Operating Margin	21.5%+4.6pp	16.9%-4.7pp	21.6%+3.0pp	18.5%-4.3pp	22.8%+1.5pp	21.3%0.0pp	21.4%+4.8pp	16.6%-15.9pp	32.5%+10.3pp	22.3%+1.6pp	20.7%+1.4pp	19.3%+1.8pp	17.4%-0.8pp	18.2%+0.9pp	17.3%
Net Margin	12.5%+3.1pp	9.4%-5.3pp	14.7%+4.5pp	10.2%-6.7pp	16.9%+5.5pp	11.4%+0.1pp	11.3%+3.4pp	7.9%-17.3pp	25.2%+12.0pp	13.2%+1.0pp	12.2%+0.7pp	11.5%+1.1pp	10.4%-0.1pp	10.5%+0.2pp	10.3%
Return on Equity	8.2%+2.2pp	5.9%-2.6pp	8.5%+2.8pp	5.7%-2.9pp	8.6%+3.0pp	5.6%+0.2pp	5.4%+2.8pp	2.6%-13.2pp	15.8%-23.9pp	39.7%+4.7pp	35.0%+4.3pp	30.6%+3.2pp	27.4%-0.2pp	27.6%+0.8pp	26.8%
Return on Assets	3.8%+1.0pp	2.7%-1.5pp	4.2%+1.4pp	2.8%-1.5pp	4.2%+1.6pp	2.7%+0.1pp	2.5%+1.3pp	1.2%-5.5pp	6.7%-2.0pp	8.6%0.0pp	8.6%+0.1pp	8.5%+0.9pp	7.6%+0.6pp	7.0%+0.5pp	6.5%
Current Ratio	0.64+0.1x	0.49+0.1x	0.38-0.1x	0.470.0x	0.47+0.2x	0.310.0x	0.350.0x	0.38-0.3x	0.73-1.9x	2.60+1.5x	1.150.0x	1.17+0.1x	1.090.0x	1.08+0.2x	0.92
Debt-to-Equity	0.510.0x	0.53+0.1x	0.39-0.1x	0.440.0x	0.460.0x	0.47-0.1x	0.55-0.1x	0.63+0.1x	0.54-1.6x	2.09+0.8x	1.32+0.2x	1.120.0x	1.100.0x	1.12+0.1x	0.99
Asset Turnover	0.300.0x	0.290.0x	0.280.0x	0.270.0x	0.250.0x	0.230.0x	0.22+0.1x	0.15-0.1x	0.27-0.4x	0.66-0.1x	0.710.0x	0.740.0x	0.73+0.1x	0.670.0x	0.64
FCF Margin	9.1%-1.7pp	10.8%+4.7pp	6.1%-11.6pp	17.7%-1.7pp	19.3%+2.2pp	17.2%-2.1pp	19.3%0.0pp	19.3%-0.3pp	19.6%+7.4pp	12.1%-1.2pp	13.3%-0.6pp	13.9%+2.5pp	11.5%+7.0pp	4.4%-4.8pp	9.2%

Metric	Q2'2610-Q	Q1'2610-Q	Q4'2510-Q	Q3'2510-Q	Q2'2510-Q	Q1'2510-Q	Q4'2410-K	Q3'2410-Q
Gross Margin	41.9%-12.2pp	52.8%-1.8pp	53.8%-2.2pp	54.3%-0.7pp	54.2%-1.2pp	54.6%-1.3pp	56.0%-0.5pp	55.0%-0.5pp
Operating Margin	8.6%-13.0pp	19.0%-3.0pp	19.6%+18.0pp	23.1%-0.1pp	21.6%-0.4pp	22.0%0.0pp	1.6%-22.8pp	23.2%-0.4pp
Net Margin	1.9%-11.2pp	6.8%-7.4pp	7.8%+11.4pp	15.4%-0.5pp	13.1%0.0pp	14.2%+1.1pp	-3.5%-21.5pp	15.8%+2.2pp
Return on Equity	0.6%-1.6pp	1.1%-1.0pp	1.4%+2.0pp	2.6%+0.1pp	2.2%+0.1pp	2.1%+0.3pp	-0.6%-3.3pp	2.5%+0.4pp
Return on Assets	0.2%-0.8pp	0.4%-0.6pp	0.6%+0.9pp	1.2%0.0pp	1.0%0.0pp	1.0%+0.1pp	-0.3%-1.6pp	1.2%+0.2pp
Current Ratio	0.48-0.2x	2.31+1.8x	0.64+0.1x	0.62+0.1x	0.64+0.1x	0.470.0x	0.49+0.1x	0.53+0.1x
Debt-to-Equity	0.86+0.3x	0.83+0.3x	0.510.0x	0.530.0x	0.56+0.1x	0.490.0x	0.53+0.1x	0.50+0.1x
Asset Turnover	0.080.0x	0.050.0x	0.080.0x	0.080.0x	0.080.0x	0.070.0x	0.080.0x	0.070.0x
FCF Margin	9.8%+2.0pp	4.2%+1.7pp	12.5%-4.3pp	12.2%-0.7pp	7.8%-6.0pp	2.5%+4.5pp	16.8%+13.1pp	12.9%+0.9pp

Note: The current ratio is below 1.0 (0.64), indicating current liabilities exceed current assets, which may suggest potential short-term liquidity concerns.

Similar Companies

Newest fiscal year on record for each company. The health score is the peer-relative Financial Health Score for that year; a dash means no score is published for it.

Company	Fiscal year	Revenue	Net income	Net margin	Market cap	Health score
Keurig Dr Pepper Inc. KDP	FY2025	$16.6B	$2.1B	12.5%	$41.6B	50/100
Monster Beverage Corporation MNST	FY2025	$8.3B	$1.9B	23.0%	$84.7B	82/100
Celsius Holdings, Inc. CELH	FY2025	$2.5B	$108.0M	4.3%	$6.9B	58/100
PepsiCo, Inc. PEP	FY2025	$93.9B	$8.2B	8.8%	$171.6B	50/100
Coca-Cola Consolidated, Inc. COKE	FY2025	$7.2B	$570.6M	7.9%	$13.0B	56/100

Where Keurig Dr Pepper Inc. Ranks

Frequently Asked Questions

What is Keurig Dr Pepper Inc.'s annual revenue?

Keurig Dr Pepper Inc. (KDP) reported $16.6B in total revenue for fiscal year 2025. This represents a 8.2% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

How fast is Keurig Dr Pepper Inc.'s revenue growing?

Keurig Dr Pepper Inc. (KDP) revenue grew by 8.2% year-over-year, from $15.4B to $16.6B in fiscal year 2025.

Is Keurig Dr Pepper Inc. profitable?

Yes, Keurig Dr Pepper Inc. (KDP) reported a net income of $2.1B in fiscal year 2025, with a net profit margin of 12.5%.

What is Keurig Dr Pepper Inc.'s EBITDA?

Keurig Dr Pepper Inc. (KDP) had EBITDA of $4.3B in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.

How much debt does Keurig Dr Pepper Inc. have?

As of fiscal year 2025, Keurig Dr Pepper Inc. (KDP) had $1.0B in cash and equivalents against $13.0B in long-term debt.

What is Keurig Dr Pepper Inc.'s gross margin?

Keurig Dr Pepper Inc. (KDP) had a gross margin of 54.2% in fiscal year 2025, indicating the percentage of revenue retained after direct costs of goods sold.

What is Keurig Dr Pepper Inc.'s operating margin?

Keurig Dr Pepper Inc. (KDP) had an operating margin of 21.5% in fiscal year 2025, reflecting the profitability of core business operations before interest and taxes.

What is Keurig Dr Pepper Inc.'s net profit margin?

Keurig Dr Pepper Inc. (KDP) had a net profit margin of 12.5% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.

Does Keurig Dr Pepper Inc. pay dividends?

Yes, Keurig Dr Pepper Inc. (KDP) paid $0.92 per share in dividends during fiscal year 2025.

What is Keurig Dr Pepper Inc.'s return on equity (ROE)?

Keurig Dr Pepper Inc. (KDP) has a return on equity of 8.2% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.

What is Keurig Dr Pepper Inc.'s free cash flow?

Keurig Dr Pepper Inc. (KDP) generated $1.5B in free cash flow during fiscal year 2025. This represents a -9.1% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.

What is Keurig Dr Pepper Inc.'s operating cash flow?

Keurig Dr Pepper Inc. (KDP) generated $2.0B in operating cash flow during fiscal year 2025, representing cash generated from core business activities.

What are Keurig Dr Pepper Inc.'s total assets?

Keurig Dr Pepper Inc. (KDP) had $55.5B in total assets as of fiscal year 2025, including both current and long-term assets.

What are Keurig Dr Pepper Inc.'s capital expenditures?

Keurig Dr Pepper Inc. (KDP) invested $486.0M in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.

How much does Keurig Dr Pepper Inc. spend on research and development?

Keurig Dr Pepper Inc. (KDP) invested $70.0M in research and development during fiscal year 2025.

Does Keurig Dr Pepper Inc. buy back shares?

Yes, Keurig Dr Pepper Inc. (KDP) spent $9.0M on share buybacks during fiscal year 2025, returning capital to shareholders by reducing shares outstanding.

How many shares does Keurig Dr Pepper Inc. have outstanding?

Keurig Dr Pepper Inc. (KDP) had 1.36B shares outstanding as of fiscal year 2025.

What is Keurig Dr Pepper Inc.'s current ratio?

Keurig Dr Pepper Inc. (KDP) had a current ratio of 0.64 as of fiscal year 2025, which is below 1.0, which may suggest potential liquidity concerns.

What is Keurig Dr Pepper Inc.'s debt-to-equity ratio?

Keurig Dr Pepper Inc. (KDP) had a debt-to-equity ratio of 0.51 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.

What is Keurig Dr Pepper Inc.'s return on assets (ROA)?

Keurig Dr Pepper Inc. (KDP) had a return on assets of 3.8% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.

What is Keurig Dr Pepper Inc.'s P/E ratio?

Keurig Dr Pepper Inc. (KDP) trades at 29.1x earnings, its market capitalization divided by net income of $1.4B net income, trailing 12 months to June 30, 2026. The market capitalization is $41.6B as of Oct 8, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.

What is Keurig Dr Pepper Inc.'s price-to-sales ratio?

Keurig Dr Pepper Inc. (KDP) trades at 2.1x sales, its market capitalization divided by revenue of $20.1B revenue, trailing 12 months to June 30, 2026. The market capitalization is $41.6B as of Oct 8, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.

What is Keurig Dr Pepper Inc.'s Altman Z-Score?

Keurig Dr Pepper Inc. (KDP) has an Altman Z-Score of 1.42, placing it in the Distress Zone (elevated bankruptcy risk). The Z-Score combines five financial ratios (working capital, retained earnings, EBIT, market capitalization, and revenue relative to total assets) to predict the likelihood of bankruptcy. Scores above 2.99 indicate financial safety while scores below 1.81 suggest financial distress. Learn more in our complete guide to financial health indicators.

What is Keurig Dr Pepper Inc.'s Piotroski F-Score?

Keurig Dr Pepper Inc. (KDP) has a Piotroski F-Score of 6 out of 9, indicating neutral financial health. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

Are Keurig Dr Pepper Inc.'s earnings high quality?

Keurig Dr Pepper Inc. (KDP) has an earnings quality ratio of 0.96x, considered mixed quality. This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

Can Keurig Dr Pepper Inc. cover its interest payments?

Keurig Dr Pepper Inc. (KDP) has an interest coverage ratio of 4.74x, meaning it can adequately cover its interest obligations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.

How financially healthy is Keurig Dr Pepper Inc.?

Keurig Dr Pepper Inc. (KDP) scores 50 out of 100 on our Financial Health Score, indicating moderate standing within its operating companies peer group. The score is a 0-100 composite of six dimensions (Profitability, Growth, Leverage, Liquidity, Cash Flow, Returns), each ranked as a percentile relative to companies in the same scoring family (banks against banks, REITs against REITs, and so on) rather than across all industries. It rates the quality of the business, not whether the stock is fairly priced, and is not financial advice. Learn more in our complete guide to financial health indicators.